Allurar Rigakafin KSD-101 Ta Samu Amincewa Da Gwaji A Kasar China: Sabon Zaɓin Maganin Rigakafi Ga Ciwon Da Ke Da Alaƙa Da EBV Yanzu Ga Marasa Lafiya Na Ƙasashen Duniya

Labari mai daɗi ya fito kwanan nan daga Cibiyar Nazarin Magunguna (CDE) ta Hukumar Kula da Kayayyakin Lafiya ta Ƙasa ta China: an amince da gwajin asibiti na allurar KSD-101, wadda Hensen Bio ta ƙirƙiro,. An nuna amfani da shi ne ga "ciwace-ciwacen jini da ke da alaƙa da EBV waɗanda ba su amsa maganin da aka saba ba."

 

Wannan maganin mai saurin yaduwa yanzu haka ana samunsa ga marasa lafiya da suka cancanta a duk duniya ta hanyar Sashen Kasa da Kasa na Asibitin Oncology na Yankin Kudu na Beijing**. Mun sadaukar da kanmu wajen fassara binciken kimiyya na zamani zuwa aikin asibiti, muna ba marasa lafiya na duniya manyan ayyukan kiwon lafiya da kuma sabon zaɓi na magani.

 

KSD-101 allurar rigakafin ƙwayoyin halitta ce ta kansa, wadda aka samo daga ƙwayoyin halittar ɗan adam kuma aka cika ta da hadaddun ƙwayoyin cuta masu alaƙa da EBV. An gabatar da sabbin binciken da aka yi daga gwajin asibiti na Phase I a taron shekara-shekara na Ƙungiyar Hematology ta Turai (EHA) na 2025, wanda ya nuna babban ƙarfinsa a fannin maganin rigakafi.

 

Binciken asibiti na Mataki na I ya yi wa marasa lafiya nau'ikan cututtukan lymphoproliferative da ke da alaƙa da kwayar cutar Epstein-Barr (EBV-LPDs), waɗanda suka haɗa da yanayi daban-daban kamar Lymphoma T-cell Angioimmunoblastic (AITL), Lymphoma NK/T-cell na hanci (ENKTL), Chronic Active Epstein-Barr Virus infection (CAEBV), Hemophagocytic Lymphoma (HLH) da ke da alaƙa da EBV, Diffuse Large B-cell Lymphoma (DLBCL), da Hodgkin Lymphoma (HL).

 

Sakamakon binciken ya nuna cewa a matsakaicin bin diddigin makonni 42.7, maganin KSD-101 ya haifar da sassauci ga cututtuka, inda yawancin marasa lafiya suka cimma kuma suka ci gaba da samun cikakkiyar sassauci (CR). Waɗannan bayanan suna ba da sabon bege ga marasa lafiya waɗanda suka gaza a cikin jiyya na yau da kullun.

 

Dangane da aminci, Abubuwan da suka shafi magani (AEs) galibi sun kasance masu sauƙi, kamar amsawar wurin allura, zazzabi, da cutar lymphadenopathy. Ba a lura da gubar Grade ≥3 ba, wanda ke nuna kyakkyawan yanayin haƙuri. Wannan yana nuna cewa KSD-101 ba wai kawai yana da tasiri ba har ma yana da aminci, yana tallafawa yuwuwar yin magani na dogon lokaci.

 

**Me Yasa Zabi Sashen Kasa da Kasa na Asibitin Oncology na Yankin Kudu na Beijing?**

 

A matsayinmu na wurin da aka amince da shi na likitanci ga marasa lafiya na ƙasashen waje, muna ba da cikakkun ayyukan likitanci na ƙasashen waje da harsuna da yawa. Tun daga kimantawa ta farko da keɓance tsarin magani zuwa bin diddigin da ke tafe, ƙungiyar ƙwararrunmu ta himmatu wajen samar da kulawa ta musamman ga kowane majiyyaci na ƙasashen waje.

 

Kada ku bari iyakokin ƙasa su takaita damar samun mafi kyawun magani. Idan kai ko ɗan gidanka yana fama da ciwon daji da ke da alaƙa da EBV kuma ba ku amsa maganin da aka saba ba, da fatan za a tuntuɓe mu nan da nan.

 

**Tuntube Mu Yanzu Don Kimanta Tsarin Magani**

 

Tawagarmu ta Sashen Ƙasashen Duniya a shirye take ta taimaka muku. Kuna iya tuntuɓar mu ta kowace hanya mai zuwa don fara tafiyarku zuwa ga ci gaba da magani:

 

- ��� Tuntuɓi ta waya: 400-880-3716

- ��� Shawarwari na WeChat: 17801183037

- ��� Imel:

- 100085_010@163.com

- myimmnet@163.com

 

**Sashen Ƙasa da Ƙasa na Asibitin Kula da Cututtukan Cututtuka na Yankin Kudu na Beijing**

Tasharku ta Duniya don Maganin Ciwon Kansa

微信图片_20241115181717


Lokacin Saƙo: Maris-12-2026